Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Cigarette smoking is associated with reduced neuroinflammation and better cognitive control in people living with HIV
    Published on 2024-12-31
    6 months ago
  • Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials
    Published on 2024-12-29
    6 months ago
  • Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study
    Published on 2024-12-23
    7 months ago
  • Epac2-mediated synaptic insertion of Ca2+-permeable AMPARs in the nucleus accumbens contributes to incubation of cocaine craving
    Published on 2024-12-18
    7 months ago
  • Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants
    Published on 2024-12-18
    7 months ago
  • Neural basis of adolescent THC-induced potentiation of opioid responses later in life
    Published on 2024-12-09
    7 months ago
  • Correction: The might of light for revealing neuropsychiatric mechanisms
    Published on 2024-12-08
    7 months ago
« Previous 1 … 16 17 18 19 20 … 143 Next »
Journal of Psychopharmacology
  • Less is more? A review of psilocybin microdosing
    Published on 2024-09-16
    10 months ago
  • The relationship between Parkinson’s disease and sexual hyperactivity secondary to drug treatment: A systematic review
    Published on 2024-09-16
    10 months ago
  • Antipsychotic medication in people with intellectual disability and schizophrenia: A 25-year updated systematic review and cross-sectional study
    Published on 2024-09-12
    10 months ago
  • Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression
    Published on 2024-09-12
    10 months ago
  • Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers
    Published on 2024-09-12
    10 months ago
  • Blackcurrant (Ribes nigrum L.) improves cholinergic signaling and protects against chronic Scopolamine-induced memory impairment in mice
    Published on 2024-09-12
    10 months ago
  • Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis
    Published on 2024-09-12
    10 months ago
« Previous 1 … 16 17 18 19 20 … 123 Next »
European Neuropsychopharmacology
  • The myth of minimum effective dose in antipsychotic treatment for patients with remitted psychosis
    Published on 2024-09-06
    10 months ago
  • Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research
    Published on 2024-09-06
    10 months ago
  • The Transdiagnostic Global Impression – Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice
    Published on 2024-09-06
    10 months ago
  • The gut-microbiome in adult Attention-deficit/hyperactivity disorder – A Meta-analysis
    Published on 2024-09-06
    10 months ago
  • Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators
    Published on 2024-09-06
    10 months ago
  • The role of biomarkers in clinical development of drugs for neuropsychiatric disorders – A pragmatic guide
    Published on 2024-09-06
    10 months ago
  • The challenges of using machine learning models in psychiatric research and clinical practice
    Published on 2024-09-06
    10 months ago
« Previous 1 … 16 17 18 19 20 … 144 Next »

   Pharma Pub